DOMINIQUE ANDERSON: Open Payments
NPI 1992289045 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 10 payments from 10 companies in 2025. Trend: 2023 $573 · 2024 $879 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 1 | $150 |
| REVANCE THERAPEUTICS, INC. | 1 | $139 |
| Amgen Inc. | 1 | $135 |
| Axsome Therapeutics, Inc. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
| Braeburn Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $14 |
Products named: DEXCOM G7 GSS (161), DAXI, KRYSTEXXA, Auvelity, SPRAVATO, BRIXADI, Wegovy, ZEPBOUND.
Industry payments across LA — which companies pay providers there.
